Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 0.5880
-0.0100 (-1.67%)
Aug 26, 2025, 4:11 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 62.04 million as of August 26, 2025. Its market cap has decreased by -31.65% in one year.
Market Cap
62.04M
Enterprise Value
43.26M
Revenue
62.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.59
Market Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has decreased from 62.49M to 62.04M, a decrease of -0.72%. That is a compound annual growth rate of -0.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 63.10M | -42.87% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | 162.93M | 14.86% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 101.68B |
| Sectra AB | 67.05B |
| Getinge AB | 56.76B |
| Camurus AB | 41.45B |
| Medicover AB | 41.14B |
| Asker Healthcare Group AB | 38.73B |
| BioArctic AB | 21.35B |
| AddLife AB | 21.03B |